Clinical implications of basic research in hepatocellular carcinoma

Area of Science:

• Hepatology and Oncology
• Radiology and Medical Imaging
• Clinical Pharmacology

Background:

• Hepatocellular carcinoma (HCC) is a primary liver cancer often diagnosed in patients with underlying cirrhosis.
• Early detection through surveillance is crucial for managing HCC, especially in high-risk populations like those with hepatitis C-related cirrhosis.

Observation:

• A 58-year-old female with hepatitis C cirrhosis presented with multiple liver nodules, diagnosed as BCLC stage C HCC with portal vein tumor thrombosis.
• Initial treatment with sorafenib was discontinued due to severe adverse events, including diarrhea and skin rash.
• Laboratory findings revealed impaired liver function (low albumin, elevated bilirubin and liver enzymes) and thrombocytopenia.

Findings:

• The patient's HCC diagnosis was confirmed via imaging, showing characteristic radiologic findings and macrovascular invasion.
• Despite being Child-Pugh class A, the tumor burden and invasion classified her as BCLC stage C, indicating advanced disease.
• Sorafenib intolerance necessitates exploration of alternative systemic therapies for advanced HCC.

Implications:

• This case underscores the challenges in managing advanced HCC, particularly regarding treatment tolerance and efficacy.
• Exploring alternative systemic agents and treatment strategies is vital for patients with advanced HCC who cannot tolerate first-line therapy.
• Further research into novel therapeutic targets and personalized treatment approaches for HCC is warranted.